Abstract
Background and Objectives: Renal artery denervation (RDN) procedure is a broadly discussed method in the treatment of resistant hypertension. Many studies report short-term (3–12 months) results for blood pressure and arterial stiffness. The primary endpoints were changes in 24 h mean systolic blood pressure (BP) and office systolic BP 48 months after RDN. The secondary endpoints were changes in aortic pulse wave velocity and impact of polypharmacy on these variables. Materials and Methods: Renal artery denervation was performed in 73 patients treated for resistant hypertension; 49 patients remained in final analysis. Patient examination was carried out before the procedure, and subsequently at 3, 6, 12, 24, and 48 months later. Patients’ antihypertensive and overall medication regimens were carefully analysed. Results: Mean 24 h arterial blood pressure lowered and was sustained at lower levels for up to 48 months; median (interequartile range—IQR) from 158(23.5)/100(14.2) to 140(26.5)/86(16.2) mmHg. Mean reduction in 24 h ambulatory systolic BP was −11 ± 25 mmHg (95% CI, −20 to −2; p < 0.001), while office systolic BP reduced by −7 ± 23 mmHg (95%CI, −24 to −1; p < 0.02). A significant reduction in median aortic pulse wave velocity 12 months after the procedure (drop from baseline 11.2 [3.15] m/s (95%CI 6.1 to 16.2) to 9.8 [2.1] m/s (95%CI 6.1 to 13.7; p = 0.002)). After 48 months, there was no worsening compared to the baseline level of 10.3 [4.0] m/s (95% CI 6.9 to 17.8) (p > 0.05). The total mean number of antihypertensive drugs remained unchanged: 5.97(±1.1) vs. 5.24 (±1.45). A higher number of pills after 48 months was associated with higher aortic pulse wave velocity (1–5 pill group: 8.1 ± 1.6 m/s; 6–10 pill group: 10.9 ± 1.8 m/s; >11 pill group: 15.1 ± 2.6 m/s) (p = 0.003). Conclusions: Antihypertensive effect after renal denervation lasts up to 48 months with no worsening of arterial stiffness compared to baseline. In our study, polypharmacy was associated with increased arterial stiffness 48 months after the procedure.
Highlights
Arterial hypertension (HTN) remains the main risk factor for death and disability in the world [1]
Resistant hypertension is defined by the American Heart Association/European Society of Hypertension/European Society of Cardiology (AHA/ESH/ESC) as elevated blood pressure (BP) remaining above goal despite the concurrent use of three or more antihypertensive medications of different classes, with one of the classes being a diuretic and all of the medications being prescribed at optimal dosage, or with controlled BP, but requiring four or more antihypertensive drugs [5]
As there is a lack of studies that investigated long-term changes after renal artery denervation (RDN), we aimed to investigate blood pressure changes and aortic stiffness 48 months after the procedure
Summary
Arterial hypertension (HTN) remains the main risk factor for death and disability in the world [1]. Resistant hypertension is defined by the American Heart Association/European Society of Hypertension/European Society of Cardiology (AHA/ESH/ESC) as elevated blood pressure (BP) remaining above goal despite the concurrent use of three or more antihypertensive medications of different classes, with one of the classes being a diuretic and all of the medications being prescribed at optimal dosage, or with controlled BP, but requiring four or more antihypertensive drugs [5]. RH is strongly linked with adverse outcomes such as coronary artery disease, heart failure, end stage renal disease, stroke and death compared to patients without RH and represents an important public health problem [2]
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have